HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lori L Jennings Selected Research

Capecitabine (Xeloda)

1/2002Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lori L Jennings Research Topics

Disease

5Alzheimer Disease (Alzheimer's Disease)
11/2023 - 12/2019
4COVID-19
04/2021 - 06/2020
3Atherosclerosis
07/2023 - 01/2019
3Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2020
2Dementia (Dementias)
07/2023 - 01/2021
2Obesity
11/2022 - 04/2021
2Autistic Disorder (Autism)
12/2005 - 05/2004
1Heart Failure
11/2023
1Cognitive Dysfunction
11/2023
1Disease Progression
01/2023
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022
1Alcoholic Fatty Liver
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Lung Diseases (Lung Disease)
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Atrophy
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Infections
01/2021
1Skin Ulcer
01/2021
1Virus Diseases (Viral Diseases)
11/2020
1Hypertension (High Blood Pressure)
05/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Atherosclerotic Plaque (Atheroma)
01/2019
1Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2018
1Myocardial Infarction
01/2018
1Metabolic Diseases (Metabolic Disease)
01/2018
1Sepsis (Septicemia)
06/2009
1Pneumonia (Pneumonitis)
06/2009
1Bacterial Infections (Bacterial Infection)
06/2009
1Apnea
12/2005
1Autism Spectrum Disorder
05/2004
1Breast Neoplasms (Breast Cancer)
01/2002
1Neoplasms (Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2002
10Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2018
6Blood Proteins (Serum Proteins)IBA
11/2023 - 01/2018
4Apolipoproteins E (ApoE)IBA
11/2023 - 01/2019
3Peptides (Polypeptides)IBA
07/2023 - 01/2002
2Amyloid (Amyloid Fibrils)IBA
10/2023 - 07/2023
2LipidsIBA
01/2023 - 01/2021
2Complement System Proteins (Complement)IBA
11/2022 - 06/2009
2Angiotensin-Converting Enzyme 2IBA
01/2021 - 11/2020
2neuroligin 3IBA
12/2005 - 05/2004
1tau Proteins (tau Protein)IBA
10/2023
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
10/2023
15-nitro-2-(3-phenylpropylamino)benzoic acidIBA
07/2023
1Insulin (Novolin)FDA Link
11/2022
1Fatty Acid-Binding ProteinsIBA
11/2022
11,5-anhydroglucitolIBA
11/2022
1LeptinIBA
11/2022
1DisintegrinsIBA
01/2022
1ThrombospondinsIBA
01/2022
1Metalloproteases (Metalloproteinases)IBA
01/2022
1ProteomeIBA
01/2021
1AngiostatinsIBA
01/2021
1ReninIBA
05/2020
1Neuroprotective AgentsIBA
12/2019
1OSM-LIF ReceptorsIBA
01/2019
1Oncostatin MIBA
01/2019
1AntibodiesIBA
01/2019
1Single-Stranded DNA (DNA, Single Stranded)IBA
01/2018
1lipoprotein-associated coagulation inhibitor (TFPI)IBA
06/2009
1ButyrylcholinesteraseIBA
12/2005
1N-acetyltalosaminuronic acid (NAT)IBA
12/2005
1Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric
12/2005
1NeuroliginsIBA
12/2005
1Capecitabine (Xeloda)FDA Link
01/2002
1Equilibrative Nucleoside Transporter 1IBA
01/2002
14-nitrobenzylthioinosineIBA
01/2002
1GemcitabineFDA Link
01/2002
1Monoclonal AntibodiesIBA
01/2002
1NucleosidesIBA
01/2002
1doxifluridineIBA
01/2002
1Fluorouracil (Carac)FDA LinkGeneric
01/2002

Therapy/Procedure

1Therapeutics
01/2021
1Drug Therapy (Chemotherapy)
01/2002